Calif. stem cell agency aims to bring therapies to trials

06/5/2009 | Bloomberg

The California Institute of Regenerative Medicine plans to provide about $20 million each to 10 or 12 research groups that hope to advance their stem cell treatments to human clinical trials within four years, said Alan Trounson, the agency's president. The agency also hopes to attract pharmaceutical firms that would invest in stem cell research, Trounson said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC